Get the Stockscreener App
0.4091
0.22%
-0.0009
Helius Medical Technologies Inc stock is traded at $0.4091, with a volume of 14,138.
It is down -0.22% in the last 24 hours and down -25.21% over the past month.
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
See More
Previous Close:
$0.41
Open:
$0.4099
24h Volume:
14,138
Relative Volume:
0.00
Market Cap:
$2.27M
Revenue:
$502.00K
Net Income/Loss:
$-8.86M
P/E Ratio:
-0.0722
EPS:
-5.67
Net Cash Flow:
$-10.71M
1W Performance:
-9.09%
1M Performance:
-25.21%
6M Performance:
-50.71%
1Y Performance:
-92.56%
1-Day Range:
$0.3901
$0.4099
1-Week Range:
$0.3901
$0.47
52-Week Range:
$0.373
$7.188
Helius Medical Technologies Inc Stock (HSDT) Company Profile
Name
Helius Medical Technologies Inc
Sector
Industry
Phone
215-944-6100
Address
642 NEWTOWN YARDLEY ROAD, NEWTOWN, PA
Compare HSDT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSDT
Helius Medical Technologies Inc
|
0.3929 | 2.27M | 502.00K | -8.86M | -10.71M | -5.67 |
|
ABT
Abbott Laboratories
|
126.50 | 221.85B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
96.25 | 142.24B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
369.17 | 140.07B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.95 | 118.98B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.41 | 40.31B | 5.72B | 4.17B | 259.90M | 6.97 |
Helius Medical Technologies Inc Stock (HSDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-24-21 | Initiated | Noble Capital Markets | Outperform |
Helius Medical Technologies Inc Stock (HSDT) Latest News
Helius Medical Unveils Revelation Neuro to Pioneer AI-Powered Neurorehabilitation - MyChesCo
Helius Medical Secures First Insurance Reimbursement for PoNS Device - MSN
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface ('BCI”) Technology Private Subsidiary - The Manila Times
Helius Medical launches AI-driven BCI subsidiary - Investing.com
Helius Medical Technologies, Inc. Announces the - GlobeNewswire
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer ... - Bluefield Daily Telegraph
Helius Medical's New AI Brain Interface Venture Aims to Transform Neurorehabilitation Without Surgery - StockTitan
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device - The Manila Times
Helius Medical Technologies, Inc. Announces First - GlobeNewswire
Helius Medical announces first reimbursement for PoNS Device - TipRanks
Major Breakthrough: Anthem BCBS Approves $15,420 Payment for Helius Medical's PoNS Device - StockTitan
Helius Medical Technologies, Inc. (NASDAQ: HSDT) Featured in Coverage of the 37th Annual ROTH Conference - Financial Content
Helius Medical Tech Stock Price, Quotes and Forecasts | NASDAQ:HSDT - Benzinga
Helius Medical Technologies Moves Closer to Medicare Reimbursement, Expands Stroke Program - MSN
Neurology Devices Market Detailed In New Research Report 2025 | - openPR
Research Reports on BELLUS Health Helius Medical Technologies, Resverlogix, and Crescita Therapeutics - ACCESS Newswire
Helius Medical faces Nasdaq delisting over bid price By Investing.com - Investing.com Canada
Helius Medical Technologies (NASDAQ:HSDT) Shares Down 5.8% – What’s Next? - Armenian Reporter
Helius Medical faces Nasdaq delisting over bid price - Investing.com
Helius Medical Technologies IncContinues Non-Compliance With Nasdaq Minimum Bid Price Requirement - Marketscreener.com
Helius Medical Technologies (NASDAQ:HSDT) Trading Down 5.8% – Should You Sell? - Defense World
Enrollment for Helius Stroke Pivotal Study Exceeds Initial Target - Physical Therapy Products
PoNS therapy shows promise for MS gait deficits - MSN
PoNSTEP Study Confirms Long-Term Benefits of PoNS Therapy for MS Patients - MSN
Helius Medical Secures Funds Through Warrant Agreements - TipRanks
HSDTHelius Medical Technologies, Inc. Latest Stock News & Market Updates - StockTitan
Helius Medical Surpasses Enrollment Target for Stroke Program - MSN
Helius Medical Technologies, Inc. Announces Exercise of - GlobeNewswire
Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study - The Manila Times
Helius Medical Technologies, Inc. Announces First Clinical - GlobeNewswire
Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term ... - The Bakersfield Californian
Helius exceeds stroke study enrollment goals By Investing.com - Investing.com Australia
Helius Medical Raises $3.7M Through Warrant Exercise at $0.751, Issues New Warrants - StockTitan
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market - The Manila Times
KBW Finsec Dividend Yield Index (KDX) QuotePress Release - The Globe and Mail
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
Dow Jones Composite Average (DOWC) QuotePress Release - The Globe and Mail
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
TSX Global Base Metals Index (TXBM) QuotePress Release - The Globe and Mail
Stock market news: Canoo saw fall of 72.18% while U.S. Energy witnessed surge of 122.45% during mid day trading - Business Upturn
Stock market today: Canoo declined by 63.15% while Asset Entities posted gains of 166.95% in early trading - Business Upturn
Dow Jumps 200 Points; 3M Posts Upbeat Q4 Results - Benzinga
Helius exceeds stroke study enrollment goals - MSN
Helius Medical Technologies, Inc. Announces Strong Enrollment of Its Stroke Pivotal Study Exceeding Initial Target - Marketscreener.com
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target - GlobeNewswire
Helius Medical Surpasses Stroke Trial Enrollment Goals for Revolutionary PoNS Device - StockTitan
Nancy Pelosi has this stock flying - RagingBull
There Is A Lot Of Upside Potential For Helius Medical Technologies Inc(NASDAQ: HSDT) - Stocks Register
Helius Medical Technologies Inc Stock (HSDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.57%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):